Wenjie Luo is a Business Operations Manager at Cambrian Biopharma. Prior to joining Cambrian, Wenjie was a senior member of the Business Development team at Cresilon, a biotechnology startup focused on hemostatic technologies that set a new gold standard for wound and trauma care. There, she led and completed numerous initiatives to better the company’s business operations and increase valuation, including securing a $3M non-dilutive capital grant to expand Cresilon’s regional footprint. She also played a key role in managing the startup’s intellectual property strategy and fundraising (Series A) activities. Wenjie holds an M.S. in Biomedical Engineering from Columbia University and a B.S. in Biological Engineering from Cornell University.
Current role